Diagnosis and Evaluation of Pancreatic Pseudocysts

Primary Imaging Modalities

The American College of Radiology recommends contrast-enhanced MRI with MRCP as the preferred imaging modality for the diagnosis and evaluation of pancreatic pseudocysts due to its superior soft-tissue contrast, ability to demonstrate ductal communication, and avoidance of radiation exposure 1, 2, 3
MRI with MRCP provides superior soft-tissue contrast and better demonstrates ductal communication compared to CT, with a sensitivity of up to 100% for thin-slice 3-D MRCP 1, 2
MRI is more sensitive than CT for identifying communication between a pseudocyst and the pancreatic duct system, and better visualizes internal septations and mural nodules which help differentiate pseudocysts from other pancreatic cystic neoplasms 1, 2, 3
The use of CT abdomen is recommended as an alternative when MRI is contraindicated or unavailable, and is particularly useful for detecting calcifications in the background parenchyma 1, 2, 4

The European Society of Gastrointestinal Endoscopy recommends endoscopic ultrasound (EUS) as an adjunct to cross-sectional imaging, not as the primary diagnostic tool, particularly in cases of diagnostic uncertainty 2, 4
EUS with fine needle aspiration (EUS-FNA) allows for cyst fluid analysis, which can help confirm the diagnosis, although it carries a small risk of infection, bleeding, or pancreatitis 1, 2, 4
Conventional ultrasound may be used for follow-up of fluid collections and pseudocysts, particularly in children or in low-resource settings, although it is less accurate than CT or MRI for initial diagnosis 5

The American College of Radiology recommends starting with contrast-enhanced MRI with MRCP for suspected pancreatic pseudocyst following acute or chronic pancreatitis, and using contrast-enhanced pancreatic protocol CT if MRI is contraindicated or unavailable 1, 2, 3
For follow-up imaging, MRI is preferred for long-term surveillance to minimize radiation exposure, while ultrasound may be used for interim follow-up of established pseudocysts 2, 5

Communication with the pancreatic duct is often present but not always visible, and the absence of solid components or mural nodules helps differentiate pseudocysts from cystic neoplasms 1, 3
Pseudocysts typically appear as well-defined fluid collections with a non-epithelialized wall of fibrous or granulation tissue, although diagnosis cannot be made prior to 4 weeks after the onset of pancreatitis 1, 3

Pseudocysts may be confused with other pancreatic cystic lesions such as intraductal papillary mucinous neoplasms (IPMNs) or mucinous cystic neoplasms, requiring careful evaluation of other features 3, 6
The accuracy of both MRI and CT remains relatively low for definitively identifying specific types of pancreatic cystic lesions, highlighting the need for careful diagnosis and follow-up 2, 4